Avricore Health (AVCRF) Investment Income (2024 - 2025)
Avricore Health (AVCRF) posted quarterly Investment Income of $172.94 for Q3 2025, up 571.83% YoY from $25.74 in Q3 2024, and up 135.03% sequentially from -$493.65 in Q2 2025.
Avricore Health (AVCRF) Investment Income (2024 - 2025) Analysis & Trends
Avricore Health has disclosed Investment Income across 2 years of filings, most recently posting $172.94 for Q3 2025.
- In Q3 2025, Investment Income rose 571.83% year-over-year to $172.94; the TTM figure through Sep 2025 stood at -$314.16 (changed N/A YoY), while the FY2025 annual figure was -$66.56, down 93.9% from the prior year.
- Investment Income advanced to $172.94 in Q3 2025, from -$493.65 in the prior quarter.
- Over the last five years, Investment Income for AVCRF reached as high as $172.94 in Q3 2025 and fell as low as -$493.65 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inv. Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | - |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | - |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | - |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | - |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | - |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | - |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | - |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | - |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | - |
| 10 | Avricore Health | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 172.94 |
| Jun 30, 2025 | -493.65 |
| Mar 31, 2025 | 43.21 |
| Sep 30, 2024 | -36.65 |